Morphosys AG Profit Margin

Morphosys AG (MOR) currently reports a profit margin of -226.08% as of March 2024. That compares with -24.18% in the prior-year period — down 834.9% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Morphosys AG's profit margin history and peer comparisons.

Morphosys AG's profit margin decreased from -24.18% to -226.08% — a 834.9% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphosys AG's profit margin of -226.08% is lower than the Healthcare sector average of 19.13%. That is roughly 1281.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Morphosys AG's current -226.08% should be judged against Healthcare norms (sector average: 19.13%) and against MOR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -226.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Morphosys AG, and consider following MOR for alerts when major investors trade the stock.